Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by ResMed Inc.
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2025
October 24, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed to Report First Quarter Fiscal 2025 Earnings on October 24, 2024
October 03, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Unveils 2030 Strategy to Drive Growth, Profitability, and Shareholder Returns
September 30, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
UPDATE -- ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health
September 30, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
UPDATE -- ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health
September 30, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health
September 30, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health
September 30, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed to Host Its 2024 Investor Day on September 30, 2024, at the New York Stock Exchange
September 10, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
Vaping Expected to Increase COPD Health and Economic Burden by 2050
September 10, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
August 28, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Expands its Board of Directors and Appoints Healthcare Executive and Seasoned Finance Leader Christopher DelOrefice to its Board
August 15, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2024
August 01, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed to Report Fourth Quarter Fiscal 2024 Earnings on August 1, 2024
July 03, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia
June 10, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy
May 23, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy
May 16, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Announces Participation in the RBCCM Global Healthcare Conference
May 07, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024
April 25, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024
April 04, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis
March 15, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed’s Smallest Full-Face CPAP Mask
March 06, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed’s New AirCurve™ 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions about Care, Deliver Personalized Support, and Drive Positive Therapy Outcomes for Patients with Sleep Apnea
February 12, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2024
January 24, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed to Report Second Quarter Fiscal 2024 Earnings on January 24, 2024
January 03, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Announces Participation in the 42nd Annual J.P. Morgan Healthcare Conference
December 27, 2023
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Notifies Customers About Updated Instructions and Labeling for Masks with Magnets Due to Potential Interference with Certain Medical Devices
December 20, 2023
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Secures Significant Victory in Patent Fight Against New York University
December 11, 2023
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
Study Estimates a 23% Increase in COPD by 2050, Representing 600 Million Patients Globally
December 07, 2023
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Adopts New Operating Model to Accelerate Long-term Growth
November 09, 2023
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2024
October 26, 2023
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.